prednisone has been researched along with Dermatitis, Eczematous in 48 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We randomly assigned 182 children (6 to 17 years of age), who had uncontrolled asthma while receiving 100 microg of fluticasone twice daily, to receive each of three blinded step-up therapies in random order for 16 weeks: 250 microg of fluticasone twice daily (ICS step-up), 100 microg of fluticasone plus 50 microg of a long-acting beta-agonist twice daily (LABA step-up), or 100 microg of fluticasone twice daily plus 5 or 10 mg of a leukotriene-receptor antagonist daily (LTRA step-up)." | 5.14 | Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. ( Bacharier, LB; Boehmer, SJ; Covar, RA; Guilbert, TW; Jackson, DJ; Larsen, G; Lemanske, RF; Martinez, FD; Mauger, DT; Morgan, WJ; Moss, MH; Sorkness, CA; Spahn, JD; Strunk, RC; Szefler, SJ; Taussig, LM; Zeiger, RS, 2010) |
| " The average daily prednisone dosage was 6." | 2.69 | High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. ( Alazard, M; Saxon, A; Speights, D; Stiehm, ER; Wakim, M; Yajima, A, 1998) |
| "Cutaneous manifestations of Hodgkin's disease are relatively uncommon." | 2.38 | Hodgkin's disease presenting in the skin: case report and review of the literature. ( Hayes, TG; Rabin, VR; Rosen, T; Zubler, MA, 1990) |
| "Treatment with prednisone, a 3-week tapering dose (60, 40, 20 mg), cleared the dermatitis." | 1.30 | Wrist dermatitis: contact allergy to neoprene in a keyboard wrist rest. ( Elston, DM; Johnson, RC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (77.08) | 18.7374 |
| 1990's | 4 (8.33) | 18.2507 |
| 2000's | 2 (4.17) | 29.6817 |
| 2010's | 4 (8.33) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Zieman, D | 1 |
| Braswell, M | 1 |
| Davis, A | 1 |
| Jackson, JD | 1 |
| Brodell, RT | 1 |
| Garcias-Ladaria, J | 1 |
| Pérez-Ferriols, A | 1 |
| Ortega-García, P | 1 |
| Diago, M | 1 |
| Lemanske, RF | 1 |
| Mauger, DT | 1 |
| Sorkness, CA | 1 |
| Jackson, DJ | 1 |
| Boehmer, SJ | 1 |
| Martinez, FD | 1 |
| Strunk, RC | 1 |
| Szefler, SJ | 1 |
| Zeiger, RS | 1 |
| Bacharier, LB | 1 |
| Covar, RA | 1 |
| Guilbert, TW | 1 |
| Larsen, G | 1 |
| Morgan, WJ | 1 |
| Moss, MH | 1 |
| Spahn, JD | 1 |
| Taussig, LM | 1 |
| Saint-Jean, M | 1 |
| Gagey-Caron, V | 1 |
| Jossic, F | 1 |
| Barbarot, S | 1 |
| Hamidou, M | 1 |
| Stalder, JF | 1 |
| Puya, R | 1 |
| Alvarez-López, M | 1 |
| Velez, A | 1 |
| Casas Asuncion, E | 1 |
| Moreno, JC | 1 |
| Muwakkit, S | 1 |
| Locatelli, F | 1 |
| Abboud, M | 1 |
| Razzouk, B | 1 |
| Wilimas, J | 1 |
| COPELLO, F | 2 |
| CAJATI, M | 1 |
| VACCARINI, G | 2 |
| WALTRIGNY, H | 1 |
| LESURE, J | 1 |
| POIGNON, J | 1 |
| DUVERNE, J | 1 |
| BONNAYME, R | 1 |
| ASRILANT, M | 1 |
| KAMINSKY, A | 1 |
| SAENZ, JM | 1 |
| EZZAOUI, JL | 1 |
| HUNZIKER, N | 1 |
| DELMOTTE, A | 1 |
| SIMKIN ZMUD, B | 1 |
| LEPETS, ME | 1 |
| HILL, LW | 1 |
| SAUER, H | 1 |
| RAUSCH-STROOMANN, JG | 1 |
| SIMONS, RD | 1 |
| PEDERSEN, KB | 1 |
| LEDIG, R | 1 |
| PIERSON, M | 1 |
| MANCIAUX, M | 1 |
| REMIGY, E | 1 |
| BARBELIN, R | 1 |
| White, JM | 1 |
| Salisbury, JR | 1 |
| Creamer, D | 1 |
| Joos, HA | 1 |
| Hilty, LB | 1 |
| Courington, D | 1 |
| Schaefer, WB | 1 |
| Block, M | 1 |
| Weiss, SJ | 1 |
| Schuval, SJ | 1 |
| Bonagura, VR | 1 |
| Johnson, RC | 1 |
| Elston, DM | 1 |
| Wakim, M | 1 |
| Alazard, M | 1 |
| Yajima, A | 1 |
| Speights, D | 1 |
| Saxon, A | 1 |
| Stiehm, ER | 1 |
| Sevel, D | 1 |
| Weinberg, EG | 1 |
| Van Niekerk, CH | 1 |
| Hayes, TG | 1 |
| Rabin, VR | 1 |
| Rosen, T | 1 |
| Zubler, MA | 1 |
| Gunnar, S | 1 |
| Johansson, O | 1 |
| Juhlin, L | 1 |
| Jaroszyńska-Weinberger, B | 1 |
| Michaëlsson, G | 1 |
| Klümper, A | 2 |
| Uehlinger, E | 2 |
| Lohmann, V | 2 |
| Weller, S | 2 |
| Strey, M | 2 |
| Emmerson, RW | 1 |
| Wilson-Jones, E | 1 |
| Godfrey, S | 1 |
| König, P | 1 |
| Tronnier, H | 1 |
| Schüle, D | 1 |
| Griggs, RC | 1 |
| Condemi, JJ | 1 |
| Vaughan, JH | 1 |
| Kobza, A | 1 |
| Ramsay, CA | 1 |
| Magnus, IA | 1 |
| Chan-Yeung, M | 1 |
| Morton, J | 1 |
| Grzybowski, S | 1 |
| Teodosieva, ES | 1 |
| Evans, DI | 1 |
| Holzel, A | 1 |
| de Graciansky, P | 1 |
| Rollier, C | 1 |
| Timsit, E | 1 |
| O'Quinn, SE | 1 |
| Isbell, KH | 1 |
| Harnack, K | 1 |
| Cruz, T | 1 |
| Reboucas, G | 1 |
| Rocha, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study[NCT04129931] | Phase 2 | 600 participants (Anticipated) | Interventional | 2019-12-19 | Recruiting | ||
| Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma[NCT02758873] | 241 participants (Actual) | Interventional | 2016-02-29 | Completed | |||
| Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)[NCT00395304] | Phase 3 | 182 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Asthma quality of life is measured as the average of 23 questions, each of which is scored from 1 (worse) to 7 (best) (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | units on a scale (Mean) |
|---|---|
| 2xICS | 0.2 |
| 1xICS + LABA | 0.3 |
| 1xICS + LTRA | 0.3 |
The ACT consists of five items, each scored as 1 (worst) to 5 (best). The five items are averaged. (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | units on a scale (Mean) |
|---|---|
| 2xICS | 1.49 |
| 1xICS + LABA | 1.87 |
| 1xICS + LTRA | 1.69 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | percentage points (Mean) |
|---|---|
| 2xICS | 2.84 |
| 1xICS + LABA | 4.87 |
| 1xICS + LTRA | 2.29 |
Change from baseline in the impulse oscillometry resistance at 5 Hertz, measured in kiloPascals per liters per second (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | kiloPascals per liters per second (Mean) |
|---|---|
| 2xICS | -0.08 |
| 1xICS + LABA | -0.09 |
| 1xICS + LTRA | -0.06 |
The methacholine PC20 is the concentration of methacholine that causes a 20% decrease in the pre-bronchodilator FEV1. The logarithm base 2 transformation converts the PC20 into doubling dilutions. (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | doubling dilutions (Mean) |
|---|---|
| 2xICS | 1.11 |
| 1xICS + LABA | 1.20 |
| 1xICS + LTRA | 1.00 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | percentage points (Mean) |
|---|---|
| 2xICS | 4.44 |
| 1xICS + LABA | 6.26 |
| 1xICS + LTRA | 4.04 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | natural logarithm of parts per billion (Mean) |
|---|---|
| 2xICS | -0.04 |
| 1xICS + LABA | -0.05 |
| 1xICS + LTRA | -0.02 |
PEFR variability is calculated as 100% times the difference between the evening and morning PEFR values, divided by the average of the evening and morning PEFR values, i.e., PEFR variability = 100% x (morning PEFR - evening PEFR)/((morning PEFR + evening PEFR)/2) (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | percentage points (Mean) |
|---|---|
| 2xICS | 2.09 |
| 1xICS + LABA | 1.61 |
| 1xICS + LTRA | 1.72 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | percentage points (Mean) |
|---|---|
| 2xICS | -0.2 |
| 1xICS + LABA | -1.2 |
| 1xICS + LTRA | -0.8 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | ratio (Mean) |
|---|---|
| 2xICS | 0.98 |
| 1xICS + LABA | 2.13 |
| 1xICS + LTRA | 0.55 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | percentage points (Mean) |
|---|---|
| 2xICS | 0.26 |
| 1xICS + LABA | 1.07 |
| 1xICS + LTRA | -0.84 |
(NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | percentage points (Mean) |
|---|---|
| 2xICS | -1.00 |
| 1xICS + LABA | -1.58 |
| 1xICS + LTRA | -1.56 |
An asthma exacerbation was defined as the administration of a course of oral/systemic prednisone for the treatment of asthma. (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | Participants (Count of Participants) |
|---|---|
| 2xICS | 49 |
| 1xICS + LABA | 35 |
| 1xICS + LTRA | 37 |
One treatment period was ranked as better than another if the total amount of prednisone received during the period was at least 180 mg less, if the number of annualized asthma-control days during the final 12 weeks of the period was increased by at least 31 days, or if the FEV1 at the end of the period was at least 5% higher. If the prednisone threshold was met, then we ignored the number of asthmacontrol days and the FEV1. If the threshold for asthma-control days was met, then we ignored the FEV1. Otherwise, the order of response was determined by the FEV1. (NCT00395304)
Timeframe: Measured during the last 12 weeks of each 16-week treatment period
| Intervention | Participants (Number) |
|---|---|
| All Participants | 161 |
2 reviews available for prednisone and Dermatitis, Eczematous
| Article | Year |
|---|---|
[Amicrobial pustulosis of the skin folds and autoimmune erythroblastopenia].
Topics: Acute Generalized Exanthematous Pustulosis; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; | 2011 |
Hodgkin's disease presenting in the skin: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Eczema; Hodgkin Disease; Humans; Male; Mechlorethami | 1990 |
4 trials available for prednisone and Dermatitis, Eczematous
| Article | Year |
|---|---|
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Agonists; Al | 2010 |
High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
Topics: Adolescent; Adult; Antibodies; Antigens, CD; B-Lymphocytes; CD40 Antigens; Cells, Cultured; Child; D | 1998 |
Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol.
Topics: Administration, Topical; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Aerosols; Anti-Inf | 1974 |
A double-blind trial of disodium cromoglycate (Intal) in the treatment of bronchial asthma.
Topics: Adult; Asthma; Bronchodilator Agents; Child; Clinical Trials as Topic; Cough; Cromolyn Sodium; Eczem | 1971 |
42 other studies available for prednisone and Dermatitis, Eczematous
| Article | Year |
|---|---|
Erythematous ear with drainage.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cephalexin; Child; Communicable Diseases; Ear Disea | 2021 |
Management of refractory telaprevir-induced dermatitis using oral corticosteroids.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antiviral Agents; Drug Eruptions; Drug Therapy | 2014 |
Treatment of severe refractory adult atopic dermatitis with ustekinumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; | 2012 |
Report of a child with vitiligo and Evans syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Anticardiolipin; Antibodies, Monoclonal; Antibodies, Mono | 2003 |
[Results of prednisone and prednisolone therapy in children and infants with eczema].
Topics: Child; Eczema; Humans; Infant; Prednisolone; Prednisone | 1957 |
[Prednisone in therapy of eczema in infants].
Topics: Child; Eczema; Humans; Infant; Prednisone | 1957 |
[Fatal accident in corticotherapy].
Topics: Accidents; Child; Eczema; Humans; Infant; Prednisone | 1957 |
[Corticotherapy of eczema in infants & Kaposi's varicelliform eruption].
Topics: Child; Eczema; Humans; Infant; Kaposi Varicelliform Eruption; Prednisone | 1957 |
[Prednisone & prednisolone in therapy of eczema in infants & young children].
Topics: Child; Eczema; Humans; Infant; Prednisolone; Prednisone | 1958 |
[Prednisone therapy as diagnostic criterion in differentiation of Leiner's disease and generalized diathetic eczema seborrhoeicum in infants].
Topics: Child; Complement C5; Dermatitis, Exfoliative; Eczema; Hereditary Complement Deficiency Diseases; Hu | 1958 |
[Therapeutic activity of triamcinolone in atopic dermatitis: comparative trials with prednisone & prednisolone].
Topics: Dermatitis, Atopic; Eczema; Fludrocortisone; Prednisolone; Prednisone; Triamcinolone | 1959 |
[Local treatment of impetigo, eczema and pyodermitis with a combination of prednisolone and hexachlorophene].
Topics: Anti-Infective Agents, Local; Dermatology; Eczema; Hexachlorophene; Humans; Impetigo; Prednisolone; | 1960 |
[Experimental eczema. 13. Prednisone, triamcinolone, G 27202 and eczema from dinitrochlorobenzene in the guinea pig].
Topics: Dinitrochlorobenzene; Eczema; Guinea Pigs; Nitrobenzenes; Phenylbutazone; Prednisone; Triamcinolone | 1961 |
[Eczema of the crackled type appearing after treatment of a follicular purpura of the leg with prednisone].
Topics: Animals; Eczema; Gastropoda; Humans; Leg; Prednisone; Purpura; Respiratory Sounds | 1960 |
[Antibiotic-corticoid association in asthma, eczema, urticaria, acute prurigo, acne rosacea and other diseases].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Asthma; Chloramphenicol; Eczema; Humans; Hypersensit | 1962 |
[ACTH AND CORTICOSTEROID HORMONES IN THE TREATMENT OF ECZEMA IN INFANTS AND YOUNG CHILDREN].
Topics: Administration, Topical; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Blood Glucose; Child; | 1963 |
SOME ADVANCES IN PEDIATRIC ALLERGY IN THE LAST TEN YEARS.
Topics: Asthma; Child; Common Cold; Diagnosis, Differential; Eczema; Food Hypersensitivity; Humans; Hypersen | 1964 |
[CLINICAL ASPECTS AND THERAPY OF STEROID DIABETES].
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Arthritis; Arthritis, | 1964 |
[COMPARATIVE STUDIES ON EXTERNAL CORTICOSTEROIDS. THE PRO AND CON OF THE ANTIBIOTIC ADDITIVE].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Dexamethasone; Eczema; Fludrocortisone; Glucocortico | 1964 |
LIPOMELANOTIC RETICULOSIS, DIAGNOSED IN STERNAL MARROW: ONE CASE.
Topics: Bone Marrow; Bone Marrow Examination; Child; Diagnosis, Differential; Drug Therapy; Eczema; Eosinoph | 1965 |
[Experiences with a chlorinated prednisone acetate in the treatment of eczema].
Topics: Acetates; Eczema; Halogenation; Humans; Prednisone | 1960 |
[Fatal adrenal atrophy after prolonged corticotherapy in an infant].
Topics: Adrenal Gland Diseases; Adrenal Glands; Atrophy; Child; Eczema; Humans; Infant; Prednisone; Purpura; | 1960 |
Eczematous changes on the hands--quiz case. Diagnosis: "Mechanic's hands" as part of the antisynthetase syndrome.
Topics: Azathioprine; Biopsy, Needle; Drug Therapy, Combination; Eczema; Female; Follow-Up Studies; Hand Der | 2005 |
Fatal disseminated scotochromogenic mycobacteriosis in a child.
Topics: Bone Marrow; Candidiasis; Child, Preschool; Eczema; Ethionamide; Female; Humans; Kanamycin; Macropha | 1967 |
Eczema and thrombocytopenia in an 8-month-old infant boy.
Topics: Administration, Topical; Anti-Inflammatory Agents; B-Lymphocytes; Blood Cell Count; Diagnosis, Diffe | 1997 |
Wrist dermatitis: contact allergy to neoprene in a keyboard wrist rest.
Topics: Adult; Anti-Inflammatory Agents; Computer Peripherals; Dermatitis, Allergic Contact; Eczema; Environ | 1997 |
Lenticular complications of long-term steroid therapy in children with asthma and eczema.
Topics: Adolescent; Adrenal Cortex Hormones; Asthma; Beclomethasone; Cataract; Child; Child, Preschool; Crom | 1977 |
Immunoglobulin E in "healed" atopic dermatitis and after treatment with corticosteroids and azathioprine.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Eczema; Female; gamma-Globulins; Humans; | 1970 |
[Treatment of complications following smallpox vaccination].
Topics: Child, Preschool; Eczema; Female; gamma-Globulins; Gangrene; Humans; Male; Prednisone; Smallpox Vacc | 1969 |
Effects of antihistamines, acetylsalicylic acid and prednisone on cutaneous reactions to kallikrein and prostaglandin E1.
Topics: Adult; Aspirin; Bradykinin; Chronic Disease; Cyproheptadine; Drug Hypersensitivity; Eczema; Female; | 1970 |
[Femoral head infarction after glucocorticoid treatment].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Anemia, Aplastic; Bone Diseases; Bone Marrow Diseases; Cor | 1967 |
Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus.
Topics: Adrenocorticotropic Hormone; Aged; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Eczem | 1968 |
[An experimental and clinical investigation concerning the antipruritic effect of pharmaceutical preparations].
Topics: Adolescent; Adult; Dermatitis, Seborrheic; Dermatologic Agents; Dermatology; Diazepam; Eczema; Femal | 1968 |
Effect of therapeutic dosages of prednisone on human immunoglobulin G metabolism.
Topics: Adult; Asthma; Centrifugation, Density Gradient; Eczema; Female; Humans; Immunodiffusion; Immunoelec | 1972 |
Photosensitivity due to the 'sunburn' ultraviolet content of white fluorescent lamps.
Topics: Aged; Eczema; Erythema; Female; Fluorescence; Humans; Lighting; Male; Middle Aged; Photosensitivity | 1973 |
[Changes in dermovascular reactions in patients with eczema during corticosteroid therapy].
Topics: Adolescent; Adult; Eczema; Female; Histamine; Humans; Male; Middle Aged; Prednisone; Skin Tests | 1969 |
Immune deficiency state in a girl with eczema and low serum IgM. Possible female variant of Wiskott-Aldrich syndrome.
Topics: Antibodies; Child; Child, Preschool; Eczema; Female; Herpes Simplex; Humans; Immunoglobulin M; Immun | 1970 |
[Aseptic bone necrosis of the femur head following glucocorticoid treatment].
Topics: Adult; Aged; Anemia, Aplastic; Bone Diseases; Diagnosis, Differential; Eczema; Female; Femur Head; G | 1967 |
[Pustular psoriasis].
Topics: Child, Preschool; Eczema; Humans; Infant; Male; Prednisone; Psoriasis; Suppuration | 1968 |
Influence of oral prednisone on eczematous patch test reactions.
Topics: Allergens; Chromates; Eczema; Female; Humans; Hypersensitivity; Male; Potassium; Prednisone; Skin Te | 1969 |
[Problems of economy and rehabilitation in climatotherapy of eczema].
Topics: Adolescent; Adult; Climate; Economics; Eczema; Germany, East; Humans; Male; Middle Aged; Prednisone; | 1965 |
Fatal strongyloidiasis in patients receiving corticosteroids.
Topics: Adult; Aminosalicylic Acids; Child; Child, Preschool; Cyclophosphamide; Dexamethasone; Diet, Sodium- | 1966 |